Skip to content Skip to sidebar Skip to footer

Cancer

AI model recognizes specific stages of breast tumor that may evolve into aggressive cancer.

Read More

The AI model is capable of recognizing specific stages of breast tumors that have a high probability of developing into invasive cancer.

Ductal carcinoma in situ (DCIS), a type of tumor that can develop into an aggressive form of breast cancer, accounts for approximately 25% of all breast cancer diagnoses. DCIS can be challenging for clinicians to accurately categorize, leading to frequent overtreatment for patients. A team of researchers from the Massachusetts Institute of Technology (MIT) and…

Read More

The NHS cancer detection instrument, known as “Mia”, has succeeded in recognizing cancers that physicians have overlooked.

Mia, an Artificial Intelligence (AI) tool, demonstrates its potential by identifying undetected cancerous indications in mammograms. It is known that early detection is crucial in treating all types of cancer, especially those with a high spread rate. Mia has the ability to identify tiny tumors that are often unnoticeable to the human eye but can…

Read More

Five professors from MIT tackle Major Cancer Challenges

Five MIT researchers—Michael Birnbaum, Regina Barzilay, Brandon DeKosky, Seychelle Vos, and Ömer Yilmaz—are part of winning teams for Cancer Grand Challenges 2024. Each team, made up of international, interdisciplinary cancer researchers, will receive $25 million over five years. Associate Professor of Biological Engineering Michael Birnbaum is heading Team MATCHMAKERS, comprised of co-investigators Regina Barzilay (Engineering Distinguished…

Read More

AI-based risk prediction provides fresh optimism for timely intervention in pancreatic cancer.

MIT Computer Science and Artificial Intelligence Laboratory (CSAIL) scientists, in collaboration with Limor Appelbaum, a scientist in the Department of Radiation Oncology at Beth Israel Deaconess Medical Center (BIDMC), have developed two machine-learning models for the early detection of pancreatic cancer. The two models PRISM and the logistic regression model both surpassed current diagnostic methods.…

Read More